Böll, Boris <br/><br/>
Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial.  [electronic resource] 

 -  British journal of haematology  04 2019 
 - 42-52 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/bjh.15741  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Dacarbazine--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Hodgkin Disease--diagnosis<br/>Humans<br/>Lenalidomide--administration & dosage<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Prognosis<br/>Treatment Outcome<br/>Vinblastine--administration & dosage